A STUDY TO FIND OUT THE EFFECTS OF DEXMEDETOMIDINE DURING LAPAROSCOPIC CHOLECYSTECTOMY OPERATION

EVALUATION OF THE EFFECT OF INTRAVENOUS DEXMEDETOMIDINE ON SEVOFLURANE ANAESTHESIA DURING LAPAROSCOPIC CHOLECYSTECTOMY: A RANDOMISED PLACEBO CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019400

Enrollment

Registered

2019-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: Administered by intravenous route as a continuous infusion from 10 minutes before the start of operation till the end of operation Control Intervention1: Dexmedetomidin

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA Grade I & II 2. Undergoing elective laparoscopic cholecystectomy 3. Giving written informed consent for the study

Exclusion criteria

Exclusion criteria: 1. History of psychiatric/neurologic illness 2. Pregnant and nursing women 3. Known allergy to any of the study drugs 4. Patients with significant abnormality of vital organs 5. Patients on beta blockers, anticonvulsants and other centrally acting medications 6. Patients with anticipated difficult airway

Design outcomes

Primary

Measure	Time frame
Total Sevoflurane Requirment Haemodynamic stability Post operative recoveryTimepoint: At the end of operation	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactSagnik Das

IPGMER and SSKM Hiospital, Kolkata

rajat.choudhuri@gmail.com9874660960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026